Athanasios Diamantopoulos (@ADiamantop) header
Athanasios Diamantopoulos (@ADiamantop) profile picture

Consultant Interventional Radiologist & Reader (Hon) #endovascular #Interventionaloncology #CLI_fighter

London, England
Joined February 2014
Photo by Athanasios Diamantopoulos (@ADiamantop)Photo by Athanasios Diamantopoulos (@ADiamantop)Photo by Athanasios Diamantopoulos (@ADiamantop)Photo by Athanasios Diamantopoulos (@ADiamantop)Photo by Athanasios Diamantopoulos (@ADiamantop)Photo by Athanasios Diamantopoulos (@ADiamantop)Photo by Athanasios Diamantopoulos (@ADiamantop)Photo by Athanasios Diamantopoulos (@ADiamantop)Photo by Athanasios Diamantopoulos (@ADiamantop)Photo by Athanasios Diamantopoulos (@ADiamantop)
First virtual ablation proctorship day using the ⁦@ProximieAR⁩ ⁦@GSTTnhs⁩ with prof Gangi & S.Ilias ⁦@narayan_karu⁩ @cirsesociety⁩ ⁦@BSIR_News⁩ ⁦@KingsImaging⁩ ⁦@BarnacleAlex⁩ ⁦⁩ ⁦@SarahAustinNHS⁩ ⁦@darkbrains⁩
6
8
72
Athanasios Diamantopoulos retweeted
This is a vote after a debate on open vs. endo- treatment for TASC D aortoiliac disease split 50/50 - 100+ experts at the STARS Symposium voting this morning. @Evocc_Trial equipoise exists!
3
8
420
Athanasios Diamantopoulos retweeted
>160 participants in @Evocc_Trial now across 25 🇬🇧 hospitals. >70% of patients approached say YES to randomisation, accepting both open & endovascular treatment. Don't deny patients their choice! 😔 ...offering everyone participation in an RCT is crucial.
Congratulations to Leicester for their randomisation yesterday! Bringing their total to 35 recruits which makes them our highest recruiter! 😃👏🥳 @a_saratzis @LeicesterCTU
7
1
24
1,731
Athanasios Diamantopoulos retweeted
Starting recruitment soon: KID @NIHRresearch trial: Does the use of CO2 via @angiodroid injection reduce acute kidney injury in #PAD endovascular/hybrid procedures? IR & vascular teams from Hull, Stoke, Leicester, STH, SGH the 1st to take part... starting in November!
2
8
30
1,474
Explore the future of vascular intervention, in a new residential meeting focussed on innovative technologies, research and treatment strategies. Prof @mo_hamady and Dr Raghu Lakshminarayan invite you to secure your place at the inaugural VITALS meeting. tinyurl.com/mak372ye
1
2
482
Explore the future of vascular intervention, in a new residential meeting focussed on innovative technologies, research and treatment strategies. Prof Mo Hamady and Dr Raghu Lakshminarayan invite you to secure your place at the inaugural VITALS meeting. tinyurl.com/mak372ye
6
7
1,080
Athanasios Diamantopoulos retweeted
If each open @Evocc_Trial site recruits 0.8 patients between now & end of the summer, we will have hit 100 participants. Support the cause! – at England, United Kingdom
5
19
1,275
Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-2 Trial: Analysis of the Timing and Causes of Death in Participants Randomised to an Infrapopliteal Vein Bypass or Best Endovascular Treatment First Revascularisation Strategy - ScienceDirect sciencedirect.com/science/ar…
3
235
Athanasios Diamantopoulos retweeted
EVOCC @evocc_trial in July 2024: 18 NHS sites open 83 participants recruited ... we are actively looking for new sites (email: [email protected]) ... and PLEASE (active sites) continue the effort; June & July have been slow months. Do not forget to screen & randomise!
7
21
858
Happy to be elected as member of the SOP committee @cirsesociety . Thank you all for the incredible support.
Dear friends and colleagues, I am standing for member of the @cirsesociety CIRSE SOP committee this year. Voting is open and any support will be very much appreciated @BSIR_News @TraineesBSIR
1
1
21
1,065
Athanasios Diamantopoulos retweeted
THANK YOU to each and every one who has been a part of this wonderful journey🙏🙏
What a great last couple of days, thank you to our amazing faculty, sponsors and attendees who came to celebrate a special anniversary STARS symposium!
2
6
28
1,692
Amazing Well done to everyone
This Post is from an account that no longer exists. Learn more
3
381
Dear friends and colleagues, I am standing for member of the @cirsesociety CIRSE SOP committee this year. Voting is open and any support will be very much appreciated @BSIR_News @TraineesBSIR
1
1
18
1,602
Athanasios Diamantopoulos retweeted
Replying to @Evocc_Trial
@Evocc_Trial Collaborators - please do not forget to screen & recruit... May has been a bit slower than expected in terms of recruitment. Let us know if we can help in some way: [email protected]
1
2
12
1,039
The next instalment in our BSIR 2024 Webinar Series will see us partner with @BSC_EU_Heart, for BASIL 3: The Discussion. The webinar will take place on Wednesday 1st May at 7pm. Register here - tinyurl.com/ykzvbau7
3
2
988
Athanasios Diamantopoulos retweeted
🔔 Join Dr Adams, Dr Diamantopoulos @ADiamantop & Dr Migliara at the Cordis Symposium @CX2024! Discover advancements in PAD treatment with Sirolimus Eluting Balloons. Uncover latest data & gain insights from clinical cases. Don't miss it! #CLIFighters #IRad #PAD #DEB @CLIFighters
3
3
297
Athanasios Diamantopoulos retweeted
– at Wandsworth, London
1
2
363
Athanasios Diamantopoulos retweeted
The @NIHR KID trial: "Preventing kidney injury using CO2 as contrast medium in patients with Peripheral Arterial Disease (PAD) & Chronic Kidney Disease (CKD) having arterial intervention" - we now have a logo! Supported by #LCTU. – at Leicester, England
1
4
1
18
1,439
Athanasios Diamantopoulos retweeted
TWO! Two more recruits to achieve the highest progression criteria within NIHR. Total recruitment target of 60! @a_saratzis @LeicesterCTU
1
1
5
1,428
Athanasios Diamantopoulos retweeted
5 days. 4 patients to hit green across ALL progression criteria🎈 for @Evocc_Trial IT'S FEASIBLE! @EndovascularU @ADiamantop @paulmoxey @LeicsVascular @LeicResearch @DanielCarradice @ChetterIan @VSGBI – at West Midlands, England
EVOCC collaborators... please don't forget. ONE WEEK left in our pilot phase. Keep screening daily! Sure we can get a few more participants into the study! 💪🏻🙏🏻
1
5
1
21
2,957